Miki T - Search Results

1

Expression of X-linked inhibitor of apoptosis protein is a strong predictor of human prostate cancer recurrence.

Seligson DB, Hongo F, Huerta-Yepez S, Mizutani Y, Miki T, Yu H, Horvath S, Chia D, Goodglick L, Bonavida B. Seligson DB, et al. Among authors: miki t. Clin Cancer Res. 2007 Oct 15;13(20):6056-63. doi: 10.1158/1078-0432.CCR-07-0960. Clin Cancer Res. 2007. PMID: 17947468

2

Prognostic significance of a combination of thymidylate synthase and dihydropyrimidine dehydrogenase activities in grades 1 and 2 superficial bladder cancer.

Mizutani Y, Wada H, Yoshida O, Fukushima M, Bonavida B, Kawauchi A, Miki T. Mizutani Y, et al. Among authors: miki t. Oncol Rep. 2002 Mar-Apr;9(2):289-92. Oncol Rep. 2002. PMID: 11836594

3

Irinotecan plus cisplatin has substantial antitumor effect as salvage chemotherapy against germ cell tumors.

Miki T, Mizutani Y, Nonomura N, Nomoto T, Nakao M, Saiki S, Kotake T, Okuyama A. Miki T, et al. Cancer. 2002 Nov 1;95(9):1879-85. doi: 10.1002/cncr.10918. Cancer. 2002. PMID: 12404281 Free article.

4

Prognostic significance of thymidine kinase activity in bladder carcinoma.

Mizutani Y, Wada H, Yoshida O, Fukushima M, Kamoi K, Miki T. Mizutani Y, et al. Among authors: miki t. Cancer. 2002 Nov 15;95(10):2120-5. doi: 10.1002/cncr.10948. Cancer. 2002. PMID: 12412165 Free article.

5

Synergistic cytotoxicity and apoptosis of JTE-522, a selective cyclooxygenase-2 inhibitor, and 5-fluorouracil against bladder cancer.

Mizutani Y, Kamoi K, Ukimura O, Kawauchi A, Miki T. Mizutani Y, et al. Among authors: miki t. J Urol. 2002 Dec;168(6):2650-4. doi: 10.1016/S0022-5347(05)64237-1. J Urol. 2002. PMID: 12442003

6

Prognostic significance of a combination of soluble Fas and soluble Fas ligand in the serum of patients with Ta bladder cancer.

Mizutani Y, Yoshida O, Ukimura O, Kawauchi A, Bonavida B, Miki T. Mizutani Y, et al. Among authors: miki t. Cancer Biother Radiopharm. 2002 Oct;17(5):563-7. doi: 10.1089/108497802760804790. Cancer Biother Radiopharm. 2002. PMID: 12470426

7

Significance of thymidine kinase activity in renal cell carcinoma.

Mizutani Y, Wada H, Yoshida O, Fukushima M, Nakao M, Miki T. Mizutani Y, et al. Among authors: miki t. J Urol. 2003 Feb;169(2):706-9. doi: 10.1097/01.ju.0000036473.23401.13. J Urol. 2003. PMID: 12544347

8

Significant antitumoral activity of cationic multilamellar liposomes containing human IFN-beta gene against human renal cell carcinoma.

Nakanishi H, Mizutani Y, Kawauchi A, Ukimura O, Shiraishi T, Hatano M, Mizuno M, Yoshida J, Miki T. Nakanishi H, et al. Among authors: miki t. Clin Cancer Res. 2003 Mar;9(3):1129-35. Clin Cancer Res. 2003. PMID: 12631618

9

Significance of thymidylate synthase activity in renal cell carcinoma.

Mizutani Y, Wada H, Yoshida O, Fukushima M, Nonomura M, Nakao M, Miki T. Mizutani Y, et al. Among authors: miki t. Clin Cancer Res. 2003 Apr;9(4):1453-60. Clin Cancer Res. 2003. PMID: 12684419

10

Isoliquiritigenin inhibits the growth of prostate cancer.

Kanazawa M, Satomi Y, Mizutani Y, Ukimura O, Kawauchi A, Sakai T, Baba M, Okuyama T, Nishino H, Miki T. Kanazawa M, et al. Among authors: miki t. Eur Urol. 2003 May;43(5):580-6. doi: 10.1016/s0302-2838(03)00090-3. Eur Urol. 2003. PMID: 12706007

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,913 results

Search Page

Filters